Ultrasonographic evidence of attenuated joint destruction within 18 weeks in early RA patients treated with infliximab.

Samankaltaisia teoksia

• JOINT DESTRUCTION IS ATTENUATED BY INFLIXIMAB IN EARLY RA PATIENTS WITH ULTRASONOGRAPHIC MARKERS OF POOR PROGNOSIS
  Tekijä: Taylor, P, et al.
  Julkaistu: (2003)
• Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis.
  Tekijä: Taylor, P, et al.
  Julkaistu: (2002)
• Ultrasonographic and radiographic evidence of attenuated joint destruction in early RA patients treated with infliximab
  Tekijä: Taylor, P, et al.
  Julkaistu: (2003)
• SIGNIFICANT CHANGES IN SONOGRAPHIC MEASURES OF JOINT VASCULARITY AND SERUM VEGF IN EARLY RA PATIENTS ON INFLIXIMAB BY 18 WEEKS OF THERAPY
  Tekijä: Taylor, P, et al.
  Julkaistu: (2002)
• Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
  Tekijä: Taylor, P, et al.
  Julkaistu: (2004)